80 Participants Needed

Time-Restricted Eating for Pregnancy with Obesity

(TRE-Preg Trial)

LT
MD
Overseen ByMary Dawn Koenig, PhD, RN
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: University of Illinois at Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study doctor and your obstetrician or midwife.

What data supports the effectiveness of the treatment Time-Restricted Eating for Pregnancy with Obesity?

The research highlights that managing weight gain during pregnancy is crucial for preventing obesity in both mothers and their children. Although specific data on time-restricted eating during pregnancy is not provided, interventions to optimize pregnancy weight gain have shown mixed success, suggesting that dietary strategies like time-restricted eating could potentially help manage weight gain effectively.12345

Is time-restricted eating safe for people with obesity?

Research shows that time-restricted eating, where food is consumed within a specific time window each day, is generally safe for adults with obesity. Studies found no significant adverse effects, and participants did not report changes in body image perception or disordered eating patterns.678910

How is time-restricted eating different from other treatments for obesity during pregnancy?

Time-restricted eating is unique because it focuses on limiting the hours during which food is consumed each day, aligning eating patterns with the body's natural circadian rhythms. This approach differs from other treatments that may focus on calorie restriction or specific dietary changes without considering the timing of food intake.211121314

What is the purpose of this trial?

In the United States, severe obesity (body mass index (BMI) ≥ 40.0 kg/m2) affects approximately 10% of females of reproductive age with Black females disproportionately burdened (16%). Severe obesity is a significant predictor of adverse perinatal outcomes including gestational diabetes mellitus, pre-eclampsia, premature birth, and at its most severe, fetal death, birth defects and a three-fold greater risk of maternal mortality - outcomes that also disproportionately affect Black females. Observational studies suggest weight maintenance and even modest body fat loss and altering the maternal metabolic milieu (availability of glucose and lipids) in the gestational period may be important to reducing perinatal health risks among pregnant females with severe obesity. The proposed research aims to assess time-restricted eating in the 2nd and 3rd trimesters of pregnancy to explore the effects on maternal weight, and perinatal health outcomes compared to standard clinical care.

Eligibility Criteria

This trial is for pregnant women with severe obesity, specifically those with a BMI of 40.0 kg/m2 or higher. It's particularly focused on Black females who are more affected by these conditions. The study aims to include individuals in their 2nd and 3rd trimesters but the specific inclusion and exclusion criteria details are not provided.

Inclusion Criteria

I was assigned female at birth.
Singleton pregnancy
Ability to provide informed consent
See 5 more

Exclusion Criteria

Deemed medically high risk
I have an autoimmune disorder like rheumatoid arthritis.
Night shift work
See 9 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in time-restricted eating with an 8-hour eating window in the 2nd trimester and a 10-hour eating window in the 3rd trimester, with weekly meetings with a nutritionist and monthly health check-ins.

20 weeks
Weekly meetings (virtual), monthly check-ins (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with data collected from labor and delivery records.

4 weeks
Data collection from electronic health records

Treatment Details

Interventions

  • Time Restricted Eating
Trial Overview The study is testing time-restricted eating during the second and third trimesters of pregnancy. Participants will follow this diet plan to see if it affects maternal weight and improves perinatal health outcomes, compared to standard clinical care received by others.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Time-restricted eatingExperimental Treatment1 Intervention
Participants randomized to the time-restricted eating arm will be instructed to eat ad libitum during an 8-hr window daily 11am - 7pm in the 2nd trimester and 10-hr eating window from 10am - 8pm in the 3rd trimester and abstain from caloric foods and beverages for the remaining 14-16 hours. During the eating window there will be no restrictions on types or quantities of foods consumed. Moreover, participants will not be required to monitor calorie intake during the ad libitum eating period. During the fasting period, participants will be encouraged to drink plenty of water and will be allowed to consume calorie-free beverages.
Group II: Standard CareActive Control1 Intervention
The standard care arm will not receive diet-related counseling. Participants will meet with study staff weekly to record health changes and to transmit weight through the text messaging platform. The remote videoconferencing visits will occur at the same day and time each week. Standard care participants will attend the in-person research data collection visits. Participants will be asked to maintain current (baseline) level of physical activity throughout the intervention.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

Findings from Research

Maternal obesity is linked to serious risks for both the mother and baby, including fetal hyperinsulinaemia and increased birthweight, which can lead to long-term obesity in the child.
Implementing preconception and antenatal counseling on diet, lifestyle, and weight management can significantly improve pregnancy outcomes for obese women, highlighting the importance of monitoring weight gain and fetal growth during pregnancy.
Placental dysfunction in obese women and antenatal surveillance strategies.Jeve, YB., Konje, JC., Doshani, A.[2015]
The weight-gain restriction program for obese pregnant women resulted in significantly more total full days of sickness absence benefits (76.68 days) compared to the control group (53.09 days), indicating a potential impact on health-related work absence during pregnancy.
Despite the intervention, there were no significant differences in the total days of pregnancy benefits between the intervention group (39.66%) and the control group (41.41%), suggesting that addressing social factors and attitudes towards sickness absence may be crucial for improving outcomes.
Effects of a weight-gain restriction programme for obese pregnant women on sickness absence and pregnancy benefits.Sydsjö, G., Monfils, WG., de Keyser, N., et al.[2021]
Obesity is a growing global health crisis, particularly among pregnant women, leading to poor obstetrical and neonatal outcomes, as well as long-term health issues for both mothers and their infants.
Current guidelines for managing obesity in pregnancy are inconsistent and confusing, lacking standard recommendations for weight gain, nutritional needs, and preventive health services, highlighting the need for clearer protocols and broader healthcare coverage for obesity treatment.
Perspectives in obesity and pregnancy.Mariona, FG.[2023]

References

Placental dysfunction in obese women and antenatal surveillance strategies. [2015]
Effects of a weight-gain restriction programme for obese pregnant women on sickness absence and pregnancy benefits. [2021]
Perspectives in obesity and pregnancy. [2023]
Optimal Gestational Weight Gain for Women With Obesity. [2023]
Optimizing weight gain in pregnancy to prevent obesity in women and children. [2023]
Safety of 8-h time restricted feeding in adults with obesity. [2019]
Acceptability of Time-Limited Eating in Pediatric Weight Management. [2023]
Effect of time restricted feeding on the gut microbiome in adults with obesity: A pilot study. [2022]
A Smartphone Intervention to Promote Time Restricted Eating Reduces Body Weight and Blood Pressure in Adults with Overweight and Obesity: A Pilot Study. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Complex physiology and clinical implications of time-restricted eating. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
The effect of a lifestyle intervention on pregnancy and postpartum dietary patterns determined by factor analysis. [2018]
[Bariatric surgery and pregnancy: literature review]. [2018]
13.United Statespubmed.ncbi.nlm.nih.gov
Perinatal outcomes in nutritionally monitored obese pregnant women: a randomized clinical trial. [2019]
14.United Statespubmed.ncbi.nlm.nih.gov
Obesity in Pregnancy: Optimizing Outcomes for Mom and Baby. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security